title: Peritonitis associated with Actinobacillus equuli in horses: 15 cases (1982-1992).
abstract: Peritonitis attributable to Actinobacillus equuli was diagnosed in 15 horses examined at the veterinary center between 1982 and 1992. In 13 horses, historical findings included acute onset of mild to severe signs of abdominal pain, lethargy, and inappetence. Two other horses had a history of weight loss for 3 to 6 weeks prior to examination. Diagnosis was based on the physical signs and laboratory findings, including results of peritoneal fluid analysis (gross characteristics, total protein, total and differential nucleated cell counts, and morphologic findings) and culture of A equuli. Actinobacillus equuli was consistently susceptible in vitro to penicillin, trimethoprim/sulfadiazine, and aminoglycosides. All horses in the study had marked clinical improvement within 24 to 48 hours of commencing antibiotic and supportive treatment. Antibiotic treatment was continued for variable periods, depending on the horse, but ranged from 5 to 21 days. In 11 horses for which follow-up information was available, long-term response to treatment was excellent, with horses returning to original activity.
authors.affiliation: Department of Animal Health, University of Sydney Camden, NSW, Australia.
authors.forename: L C
authors.initials: LC
authors.lastname: Golland
authors.forename: D R
authors.initials: DR
authors.lastname: Hodgson
authors.forename: J L
authors.initials: JL
authors.lastname: Hodgson
authors.forename: M A
authors.initials: MA
authors.lastname: Brownlow
authors.forename: D R
authors.initials: DR
authors.lastname: Hutchins
authors.forename: R J
authors.initials: RJ
authors.lastname: Rawlinson
authors.forename: M B
authors.initials: MB
authors.lastname: Collins
authors.forename: S A
authors.initials: SA
authors.lastname: McClintock
authors.forename: A L
authors.initials: AL
authors.lastname: Raisis
mesh_terms: D000188:Actinobacillus / Q000302:isolation & purification*; D000189:Actinobacillus Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000382:microbiology / Q000662:veterinary; D005260:Female; D005500:Follow-Up Studies; D006734:Horse Diseases / Q000188:drug therapy / Q000382:microbiology*; D006736:Horses; D008297:Male; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents